CTDH

 
Class A Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 3/20/2017
Contact Info
  • 6714 NW 16th Street
  • Suite B
  • Gainesville, FL 32653

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000922247
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2860 - Industrial Organic Chemicals
Incorporated In: FL, USA
Year of Inc. 1992
Employees 6 a/o Mar 17, 2017
Company Officers/Contacts
N. Scott Fine CEO
Jeffrey L. Tate COO, Chief Scientific Officer
Kevin J Strattan VP, Fin.
Company Directors
N. Scott Fine Chairman
Joseph J. Farnan
F. Patrick Ostronic
Markus W. Sieger
Jeffrey L. Tate
Company Notes
  • Formerly=Cyclodextrin Technologies Development, Inc. until 5-00
Service Providers
Accounting/Auditing Firm
WithumSmith+Brown
180 S. Orange #1150
Suite 1150
Orlando, FL, 32801
United States

Legal Counsel
Fox Rothschild LLP
3800 Howard Hughes Pky.
Suite 500
Las vegas, NV, 89169
United States

Investor Relations Firm
Sitrick Brincko Group, LLC
1801 W. Olympic Blvd
Pasadena, CA, 91109-1102
United States

CTDH Security Details
Share Structure
Market Value1 $36,552,917 a/o Aug 21, 2017
Authorized Shares 100,000,000 a/o Jul 31, 2017
Outstanding Shares 73,105,834 a/o Jul 31, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 16,005,303 a/o Apr 11, 2016
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 112 a/o Mar 17, 2017
Short Selling Data
Short Interest 840 (147.06%)
May 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security